GS-441524 for COVID-19 SAD, FE, and MAD Study in Healthy Subjects

Conditions: COVID-19 Interventions: Drug: GS-441524; Drug: Placebo Sponsors: National Center for Advancing Translational Sciences (NCATS); Leidos Biomedical Research, Inc.; ICON Government and Public Health Solutions, Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials